However, low NBR1 expression had no significant correlation with DFS of ccRCC patients with N1 stage, metastasis, G1+G2 stage, T3+T4 stage, TNM (III+IV) or female (Supplementary Figure 3A-3E). This evidence concerns the gene NBR1 and nonpapillary renal cell carcinoma.